Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 9.6 USD -3.61%
Market Cap: 546.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of DSGN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DSGN Intrinsic Value
Not Available
Base Case Scenario
Compare DSGN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DSGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Design Therapeutics Inc

Current Assets 209m
Cash & Short-Term Investments 206m
Receivables 1.4m
Other Current Assets 1.7m
Non-Current Assets 2.7m
PP&E 2.7m
Current Liabilities 11.2m
Accounts Payable 1.9m
Accrued Liabilities 9.3m
Non-Current Liabilities 877k
Other Non-Current Liabilities 877k
Efficiency

Free Cash Flow Analysis
Design Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Design Therapeutics Inc

Revenue
0 USD
Operating Expenses
-78m USD
Operating Income
-78m USD
Other Expenses
10.5m USD
Net Income
-67.4m USD
Fundamental Scores

DSGN Profitability Score
Profitability Due Diligence

Design Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Design Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DSGN Solvency Score
Solvency Due Diligence

Design Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Design Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DSGN Price Targets Summary
Design Therapeutics Inc

Wall Street analysts forecast DSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DSGN is 11.99 USD with a low forecast of 7.07 USD and a high forecast of 15.75 USD.

Lowest
Price Target
7.07 USD
26% Downside
Average
Price Target
11.99 USD
25% Upside
Highest
Price Target
15.75 USD
64% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Design Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DSGN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DSGN Insider Trading
Buy and sell transactions by insiders